Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
29
Number of overlapping holdings
33.0%
% of WDNA's 91 holdings also in GNOM
69.0%
% of GNOM's 42 holdings also in WDNA
Overlap by Weight
Sector Drift (WDNA minus GNOM)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in WDNA |
Weight in GNOM |
Overlap | |
|---|---|---|---|---|
 |
NATERA INC | 2.2% | 4.5% | 2.2% |
|
SAREPTA THERAPEUTICS INC | 1.7% | 3.3% | 1.7% |
|
VERTEX PHARMACEUTICALS INC | 1.6% | 1.9% | 1.6% |
|
MYRIAD GENETICS INC | 1.4% | 3.8% | 1.4% |
|
BEAM THERAPEUTICS, INC. | 1.4% | 2.8% | 1.4% |
Position Highlights (Non-Overlapping Exposures)
WDNA Overweight Relative to GNOM
|
TWIST BIOSCIENCE CORP. | 4.3% |
 |
NOVOZYMES A/S-B SHARES | 2.7% |
|
BLUEPRINT MEDICINES CORP. | 2.6% |
|
GERON CORP | 2.5% |
|
AGIOS PHARMACEUTICALS INC | 2.4% |
|
FATE THERAPEUTICS INC | 2.2% |
|
VERICEL CORPORATION | 2.1% |
|
ELI LILLY & CO | 2.1% |
|
IOVANCE BIOTHERAPEUTICS INC | 1.7% |
|
BRIDGEBIO PHARMA, INC. | 1.6% |
WDNA Underweight Relative to GNOM
 |
ENI SPA-SPONSORED ADR | -7.9% |
|
AVIDITY BIOSCIENCES INC | -5.1% |
|
ALNYLAM PHARMACEUTICALS INC | -4.9% |
|
LEGEND BIOTECH CORPORATION SPONSORED | -3.5% |
 |
BIONTECH SE SPONSORED ADR | -3.4% |
|
ULTRAGENYX PHARMACEUTICAL IN | -3.1% |
|
BIO-TECHNE CORPORATION | -3.0% |
|
VERACYTE INC | -2.9% |
 |
GENSCRIPT BIOTECH CORPORATION | -2.8% |
|
ROCKET PHARMACEUTICALS, INC. | -2.7% |